09:04:01 Europe / Stockholm

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande


ListaOAX Equities
Aqua Bio Technology är ett norskt bolag verksamma inom kosmetikabranschen. Bolaget utvecklar, tillverkar och kommersialiserar ingredienser som används inom ett flertal kosmetiska produkter världen över. Störst verksamhet återfinns inom lösningar för hudvårdsprodukter. Merparten av bolagets produkter säljs på en global marknad via diverse distributörer. Bolaget grundades 2004 och har sitt huvudkontor i Lysaker.


2022-08-24 Kvartalsrapport 2022-Q2
2022-06-10 Ordinarie utdelning ABT 0.00 NOK
2022-06-09 Årsstämma 2022
2022-04-29 Bokslutskommuniké 2021
2021-08-25 Kvartalsrapport 2021-Q2
2021-06-10 Ordinarie utdelning ABT 0.00 NOK
2021-06-09 Årsstämma 2021
2021-04-30 Bokslutskommuniké 2020
2020-09-11 Extra Bolagsstämma 2020
2020-08-26 Kvartalsrapport 2020-Q2
2020-06-11 Ordinarie utdelning ABT 0.00 NOK
2020-06-10 Årsstämma 2020
2020-04-15 Bokslutskommuniké 2019
2019-08-28 Kvartalsrapport 2019-Q2
2019-06-06 Ordinarie utdelning ABT 0.00 NOK
2019-06-05 Årsstämma 2019
2019-04-24 Bokslutskommuniké 2018
2019-01-07 Extra Bolagsstämma 2019
2018-08-22 Kvartalsrapport 2018-Q2
2018-05-30 Årsstämma 2018
2018-02-21 Bokslutskommuniké 2017
2017-08-16 Kvartalsrapport 2017-Q2
2017-06-08 Ordinarie utdelning ABT 1.00 NOK
2017-06-07 Årsstämma 2017
2017-02-15 Bokslutskommuniké 2016
2016-11-18 Bonusutdelning ABT 1
2016-11-17 Kvartalsrapport 2016-Q3
2016-11-17 Extra Bolagsstämma 2016
2016-08-17 Kvartalsrapport 2016-Q2
2016-06-09 Ordinarie utdelning ABT 1.50 NOK
2016-06-08 Årsstämma 2016
2016-05-11 Kvartalsrapport 2016-Q1
2016-02-10 Bokslutskommuniké 2015
2015-11-18 Kvartalsrapport 2015-Q3
2015-08-19 Kvartalsrapport 2015-Q2
2015-06-04 Ordinarie utdelning ABT 1.00 NOK
2015-06-03 Årsstämma 2015
2015-05-13 Kvartalsrapport 2015-Q1
2015-02-11 Bokslutskommuniké 2014
2014-11-26 Kvartalsrapport 2014-Q3
2014-08-20 Kvartalsrapport 2014-Q2
2014-06-11 Årsstämma 2014
2014-05-21 Kvartalsrapport 2014-Q1
2014-02-12 Bokslutskommuniké 2013
2013-11-27 Kvartalsrapport 2013-Q3
2013-08-21 Kvartalsrapport 2013-Q2
2013-06-13 Kapitalmarknadsdag 2013
2013-06-12 Ordinarie utdelning
2013-06-11 Årsstämma 2013
2013-05-22 Kvartalsrapport 2013-Q1
2013-02-13 Bokslutskommuniké 2012
2012-11-27 Kvartalsrapport 2012-Q3
2012-08-28 Kvartalsrapport 2012-Q2
2012-06-14 Årsstämma 2012
2012-05-23 Kvartalsrapport 2012-Q1
2012-02-17 Bokslutskommuniké 2011
2011-11-30 Kvartalsrapport 2011-Q3
2011-08-29 Kvartalsrapport 2011-Q2
2011-06-17 Ordinarie utdelning
2011-06-16 Årsstämma 2011
2011-05-30 Kvartalsrapport 2011-Q1
2011-02-18 Bokslutskommuniké 2010
2021-12-07 21:27:39

7.12.2021 21:27:37 CET | Aqua Bio Technology ASA | Non-regulatory press releases

Cosmed (Norway) is the first distributor to launch Moana Skincare broadly in Norway and has a distribution model that covers about approx. 900 stores. Cosmed is actively using Moana Skincare seminars, Instagram, Facebook and influencers in its commercialization process and has established a new physical Cosmed store at Lillestrøm Torv for their skincare products. ABT received the first order from Cosmed in August 2021. Cosmed will also commence distribution of B Natural in Norway.

Sitil Bohemia (Prague) is distributing Moana Skincare, Seidr and Seidr Clinique in the Czech Republic and Slovakia via the online shop Klidnesiuzivam supported by inhouse social media team on Facebook and Instagram. ABT has received the first orders for both Moana Skincare, Seidr and Seidr Clinique.

Maikiwi Ltd (Auckland) is distributing Moana Skincare in Mainland China and ABT received the first order on Moana Skincare in September 2021 since the new distribution agreement was entered into in August 2021. 

D & S Maisey Limited (Auckland and Manila) has a letter of intent for the exclusive distribution of Moana Skincare in Japan and the Philippines. The registration documents for Japan are under review, and preparation for launch is ongoing.

Al-Dawaa Pharmacies (Saudi Arabia) has started the registration process of Moana Skincare in Saudi Arabia and contemplates an initial launch of Moana Skincare to 50 pharmacies across Saudi Arabia. The registration process is delayed due to an organizational change in Al-Dawaa, so the launch is expected to take place in 2022.  

DNO Group International Trading (Hong Kong) is currently evaluating Moana Skincare. DNO Group International Trading markets and distributes third party beauty products in seven Asian markets that all are enjoying rapid growth.

DBK Pharmaceuticals S.A.E. (Egypt) is a fast-growing company engaged in the marketing and sales of high-end cosmetics as well as other consumer goods in Egypt. There is a delay in the registration process, but subject to completion of the registration process, ABT has received its first order on Moana Skincare.

Moana Active Skincare Ltd (New Zealand) is one of the three producers of the Moana Skincare Brand and has a distribution agreement for New Zealand and Australia, retaining ABT's local presence and knowledge of Moana Skincare Brand origin. Moana Active Skincare Ltd. will participate in and facilitate a contemplated rebranding of the Moana Skincare Brand. ABT has received its first order on Moana Skincare.

Launch of Seidr, Seidr Clinique and B Natural

Covid 19-issues delayed the production (lock-down) and delivery of products (logistics) following this Summer's launch, but ABT has received good attention in the market and expects to enter into new distribution agreement in Europe for these brands. Sitil Bohemia is the first Seidr and Seidr Clinique distributor in Europe and Cosmed are ready for B Natural distribution in Norway.  

Production & Logistics

ABT has previously entered into a manufacturing agreement with the newly incorporated Moana Active Skincare Ltd for the production of Moana Skincare. This company will also distribute Moana Skincare in New Zealand and Australia. To secure timely production and supply of Moana Skincare and B Natural, Pauling Industries in New Zealand and DCP Dermoscience in Canada will also produce Moana Skincare and B Natural for ABT in the future.

Atyp – Advertising and Media Agency

ABT will hire ATYP to increase ABTs skincare product visibility and recognition in the market.  Atyp is a recognized full-service hybrid agency that aims to develop creative solutions for market share growth and brand recognition through seamlessly integrating brand strategy, creativity, design, media performance and technology.

Restorsea LLC

Restorsea was in 2012 given exclusive and global sub-licensing rights to AquabeautineXL™, ABT’s proprietary technology until 2032. Restorsea sells its own products series based on AquabeautineXL™ through its own website, Amazone.com, appr. 134 physician clinics in the USA, as well as through clinics and websites in Brazil. In 2021 Restorsea announced licensing agreements with Nasdaq-listed LifeMD and Nasdaq-listed Hydrafacial. Hydrafacial launched key products based on AquabeautineXL™ in February 2021 and LifeMD expects to launch a NAVA MD products based on ABT’s proprietary technology in 2022.

In November 2021 Restorsea's launched several products from its PRO-line in South Korea. South Korea is one of the top 10 beauty markets in the world, representing nearly 2.8 percent of the global market and it is known that it is a long process to have cosmetic products successfully registered in South Korea. The products are distributed online through Shilla IPARK Duty Free Shop, the world's largest downtown duty-free store.

ABT's exclusive supply and license agreement with Restorsea has so far provided income of more than USD 21 M to ABT. Restorsea’s supply and license agreement are subject to Restorsea exercising its options to extend its exclusivity from 2022 to 2027, where the payments for continued exclusivity are due in 2022 (USD 2.5M) and 2027 (USD 2.5M).  ABT receives royalties on sale of AquabeautineXL™, end products and licensing fees from sub-license agreements.

ABT's income from royalties and sale of AquabeautineXL™ increased in 2021 and the positive trend from Restorsea's commercialization increases the likelihood that ABT will receive additional renewal payments (USD 2.5M in 2022) and increased revenue from the sale of ingredients and royalties.

R&D Project related to production of Aquabeautine XL

ABT expects to complete the first step of its R&D project related to the production of
Aquabeautine XL during first half of 2022. Besides facilitating a larger automation of the production process, ABT also hope to further increase the sustainability of its key ingredient based on its proprietary technology


For further information, please contact CEO Håvard Lindstrøm mobile phone +47 941 32 288.

Aqua Bio Technology is developing and commercializing sustainable biotechnology for use in skincare products. ABT's cosmetics ingredients are highly effective and they provide the cosmetics industry with natural alternatives to traditional ingredients. ABT is also marketing and distributing natural skincare products developed by partners towards consumers and professional users. ABT's focus on commercialization and development of natural ingredients and natural skincare products has been, and will continue to be, an important part of the Company's strategy going forward. Aqua Bio Technology is listed on the Euronext Expand market of the Oslo Stock Exchange.


Disclosure regulation

This information is subject of the disclosure requirements pursuant to section of 5-12 of the Norwegian Securities Trading Act.


About Aqua Bio Technology ASA

Aqua Bio Technology (ABT) is developing and commercializing sustainable
biotechnology for use in skin care products. ABT's cosmetics ingredients are
highly effective and they provide the cosmetics industry with natural
alternatives to traditional ingredients. ABT is also marketing and distributing
natural skin care products developed by partners towards consumers and
professional users. Aqua Bio Technology is listed on Euronext Expand.